Have you or your loved ones been diagnosed with venous thrombosis?

You may be eligible to participate in a venous thrombosis clinical trial.

Have you or your loved ones been diagnosed with venous thrombosis? You may be eligible to participate in a venous thrombosis clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Venous Thrombosis Clinical Trial in Taipei
NCT03945045 | Interventional

Have you or your loved ones been diagnosed with venous thrombosis?

You may be eligible to participate in a venous thrombosis clinical trial.

Have you or your loved ones been diagnosed with venous thrombosis? You may be eligible to participate in a venous thrombosis clinical trial.

Active not recruiting

Male & Female

20 - 99

Years old

This study has recruited 201 Participants

To compare IJV and SCV as the implantation site of TIVAD and its associated thrombotic or occlusion rate, our study plans to enroll 240 patients with cancer who require central line TIVADs and randomizes them with 1:1 ratio to receive the TIVAD implantation at SCV or IJV. After the implantation, the patients will be regularly followed through phone contact and chart review for 2 years, and any symptomatic thrombosis or occlusion will be found during chemotherapy injection or regular push-pull heparin saline flush every 6 weeks as our hospital care protocol. To detect any asymptomatic thrombosis, the patients will also receive screening vascular ultrasound at 2 weeks, 2 months, and 6 months postoperatively. The study primary endpoints include any infection, asymptomatic thrombosis found by screen ultrasound, and clinically symptomatic thrombosis or occlusion and major mechanical failure/dislocation of TIVAD.